Actively Recruiting

Phase 4
Age: 18Years +
FEMALE
NCT06428669

Effect of Nitropaste in Chest Masculinizing Surgery

Led by University of Virginia · Updated on 2024-06-06

256

Participants Needed

1

Research Sites

167 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Nitropaste is a topical agent that contains 2% nitroglycerin. It is an effective vascular smooth dilator, with more powerful effect on venous vasculature than arterial vasculature. While its main indication is for angina pectoris, there have been many studies showing improved survival of axial and random pattern flaps. Furthermore, recent clinical studies highlight significantly decreased mastectomy flap wound complication and need for sharp debridement. Nitropaste has low rates of side effects and is very well tolerated in general. To this date, there's no study that investigates its utility on patients who are undergoing chest masculinizing surgery. The purpose of this study is to investigate the potential utility of nitropaste in reducing rates of wound complications in patients undergoing chest masculinizing surgery.

CONDITIONS

Official Title

Effect of Nitropaste in Chest Masculinizing Surgery

Who Can Participate

Age: 18Years +
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Any adult (18 or older) patients of any gender identity who are undergoing chest masculinizing surgery with double incision and free nipple grafting.
Not Eligible

You will not qualify if you...

  • Minor patients (younger than 18)
  • Anyone who is not receiving free nipple grafting
  • Anyone who is not using the double incision pattern
  • Prisoners
  • Anyone allergic to nitropaste
  • Anyone taking phosphodiesterase inhibitors (e.g., Sildenafil, tadalafil, vardenafil)
  • Anyone taking soluble guanylate cyclase stimulators (e.g., riociguat)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of Virginia Medical Center

Charlottesville, Virginia, United States, 22902

Actively Recruiting

Loading map...

Research Team

R

Rachel H Park, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here